← Cancer Treatment and Research Communications
Papers in Cancer Treatment and Research Communications
Page 2 · newest first
- Prognostic Value of Chemotherapy-Related Mean Corpuscular Hemoglobin (MCH) Kinetics in Patients with Non-Small Cell Lung Cancer Receiving Adjuvant ChemotherapyCancer Treatment and Research Communications · 2026
- Casein-Based Nanocarriers for Myricetin Delivery: Enhancement of Apoptosis and Inhibition of Angiogenesis in Gastric Adenocarcinoma CellsCancer Treatment and Research Communications · 2026
- HHV-6 Reactivation in the Era of CAR T-Cell Therapy: A Systematic Review of Emerging ChallengesCancer Treatment and Research Communications · 2026
- Human Microbiome Influence on Head and Neck CancerCancer Treatment and Research Communications · 2026
- Brain Metastases in Gastrointestinal Cancer Patients: A Ten-Year Retrospective StudyCancer Treatment and Research Communications · 2026
- Bioinformatics and experimental insights into LINC01605 and the miR-101-3p/BIRC5 axis in oral squamous cell carcinoma pathogenesis and clinical outcomesCancer Treatment and Research Communications · 2026
- Correlation between chemotherapy in hepatocellular carcinoma and the risk of second primary malignanciesCancer Treatment and Research Communications · 2026
- Characterization of real-world clinical and pathological differences between HER2-0 and HER2-low localized breast cancerCancer Treatment and Research Communications · 2026
- Progression Phenotypes to anti–PD-(L)1 Therapy and Subsequent Management of Patients with Metastatic NSCLC: A Real-World Cohort StudyCancer Treatment and Research Communications · 2026
- Utilization of Palliative Care Service among Cancer Patients in Public Hospitals of Ethiopia: A facility-based cross-sectional studyCancer Treatment and Research Communications · 2026
- Feasibility of Quality Indicators to assess the Prevalence of Guideline Adherence in a German Cohort of Patients with Advanced or Metastatic Breast Cancer: Results of the BRE-BY-MED studyCancer Treatment and Research Communications · 2026
- miR-155 and the Orchestration of Cell-Death Evasion and Chemoresistance in Cancer: Isoform-Specific Mechanisms and Therapeutic OpportunitiesCancer Treatment and Research Communications · 2026
- Whipple procedure complications and outcomes: single center experience in KazakhstanCancer Treatment and Research Communications · 2026
- Prognostic Impact of N1 Lymph Node Micrometastasis in T1-2a Non-small Cell Lung CancerCancer Treatment and Research Communications · 2026
- Rechallenge chemotherapy with carboplatin plus paclitaxel or nab-paclitaxel for patients with non-small cell lung cancer and interstitial lung disease: A multicenter retrospective studyCancer Treatment and Research Communications · 2026
- The Role of Histone Acetylation in Mediating the Anticancer Effects of Polyphenols: Insights from Genistein, Resveratrol, Quercetin, Curcumin, and Epigallocatechin-3-gallateCancer Treatment and Research Communications · 2026
- PARK7 (DJ-1) indicates favorable prognosis and correlates with estrogen-receptor status and Nε-carboxymethyl-lysine (CML) accumulation in breast cancerCancer Treatment and Research Communications · 2026
- Barriers to clinical implementation for novel therapies and biomarker testing in the community practice oncology setting: A CLDN18.2 case studyCancer Treatment and Research Communications · 2026
- The Genomic, Transcriptomic, and Immunologic Landscape of TEM8 (ANTXR1) in Neuroendocrine Neoplasms (NENs) including Small-Cell Lung Cancer (SCLC)Cancer Treatment and Research Communications · 2026
- Gain of Chromosome 1q and MYCN Characterize Unique Subgroups of Asian Wilms Tumor PatientsCancer Treatment and Research Communications · 2026
- Rethinking Local Therapy in de novo Metastatic Breast Cancer: The Emerging Role of RadiotherapyCancer Treatment and Research Communications · 2026
- Systematically Investigating the Differential Impact of m1A Regulatory Factors on Cancer Prognosis and Their Potential as Diagnostic BiomarkersCancer Treatment and Research Communications · 2026
- Integrating the Silva Pattern into Clinical Practice: A Prognostic Tool for Tailoring Surgery and Adjuvant Therapy in Cervical AdenocarcinomaCancer Treatment and Research Communications · 2026
- Cervical Cancer during Pregnancy: Management and Maternal and Perinatal OutcomesCancer Treatment and Research Communications · 2026
- The Mesopancreas remains at risk in primary resectable pancreatic cancer patients: time to reappraise resectability criteria?Cancer Treatment and Research Communications · 2026
- Can we define the clinical variables predicting T0 after neoadjuvant systemic therapy in bladder cancer?Cancer Treatment and Research Communications · 2026
- Magnesium Depletion Score and Risk of Skin Cancer and Mortality: Evidence from NHANES 1999–2018 with Mediation by PhenoAgeCancer Treatment and Research Communications · 2026
- Urinary mRNA Profiling of Autophagy-Related Genes ATG5, ATG7, MAP1LC3B, and mTOR in Non-Muscle Invasive Bladder Cancer (NMIBC)Cancer Treatment and Research Communications · 2026
- Optimizing mercaptopurine therapy in indian pediatric ALL: The role of TPMT and NUDT15 genetic polymorphismsCancer Treatment and Research Communications · 2026
- Anticancer, antiapoptotic, and antimigratory effects of Enterococcus faecium-obtained postbiotics on colorectal cancer cells: In vitro studiesCancer Treatment and Research Communications · 2026
- Surgical resection for primary retroperitoneal liposarcoma: Analysis of 153 Patients Treated and Followed at a Single InstitutionCancer Treatment and Research Communications · 2026
- Association between biochemical and histopathological parameters in the clinical assessment of prostate tumors in a resource-limited setting in northern CameroonCancer Treatment and Research Communications · 2026
- A radiomics-based interpretable model to distinguish Xp11.2/TFE3 translocation renal cell carcinoma and common types of renal cell carcinoma on CT imagesCancer Treatment and Research Communications · 2026
- The Emerging Influences of Telomere and Telomerase in Inflammatory Bowel Disease and Cancer ProgressionCancer Treatment and Research Communications · 2026
- Apoptosis induction and migration suppression through regulation of IGF-1R/FoxO signaling pathways in Panc1 pancreatic cancer cells by hAMSCs secretome: An in vitro cell-based therapyCancer Treatment and Research Communications · 2026
- Harnessing the Power of Oncolytic Viruses for Advancing Cancer TherapyCancer Treatment and Research Communications · 2026
- Establishing a Tumor-Specific Center to Enhance Multidisciplinary Cancer Care in a General Hospital: A Model for Clinical Quality and InnovationCancer Treatment and Research Communications · 2026
- Nanovaccines in Cancer Immunoprevention and Immunotherapy: Current Insights and Future DirectionsCancer Treatment and Research Communications · 2026
- Patient-reported satisfaction with thermal water-based cosmetic products in breast cancer patients undergoing chemotherapy: a feasibility studyCancer Treatment and Research Communications · 2026
- Evaluation of a Gene Expression Panel for Prognostic Stratification in High-Risk Prostate CancerCancer Treatment and Research Communications · 2026
- PSMA for HCC: A New Frontier in Precision Medicine for Liver Cancer?Cancer Treatment and Research Communications · 2026
- Circular RNAs as Emerging Regulators of Mitochondrial Function and DiseaseCancer Treatment and Research Communications · 2026
- Tissue and circulating proprotein convertase subtilisin/Kexin type 9 (PCSK9) as promising prognostic biomarkers for curative-intent colorectal liver metastases resection: A case-control studyCancer Treatment and Research Communications · 2026
- Prognostic value of the baseline triglyceride-glucose-body mass index in small cell lung cancer undergoing chemoimmunotherapy: A multicenter retrospective studyCancer Treatment and Research Communications · 2026
- Clinical role of breast ultrasound surveillance in detecting locoregional recurrences after bilateral mastectomiesCancer Treatment and Research Communications · 2026
- Determinants of delayed postoperative radiation therapy in breast cancer patients undergoing neoadjuvant chemotherapy: A subanalysis of the AMAZONA III prospective cohortCancer Treatment and Research Communications · 2026
- Surviving the siege: A review on the metabolic hallmarks of cancer dormancyCancer Treatment and Research Communications · 2026
- CAR T- cell therapy: A promising novel approach for treatment of cancerCancer Treatment and Research Communications · 2026
- Treatment and outcomes of patients with HR+/HER2− early breast cancer in a real-world setting in GermanyCancer Treatment and Research Communications · 2026
- Securinine bolsters anti-tumor immunity by promoting CD8⁺ T cell activationCancer Treatment and Research Communications · 2026